HKEX Stock Code: 01093English|繁體|简体

1Q2023 Results

  • Revenue was RMB8,053 million, an increase of 2.3% compared with the same period in 2022
  • Profit attributable to shareholders was RMB1,429 million, an increase of 1.7% compared with the same period in 2022

Highlight - 1Q2023

Revenue
RMB8,053mn, +2.3%
Underlying profit attributable to shareholders
RMB1,545mn, +0.1%
Profit attributable to shareholders
RMB1,429mn, +1.7%
Basic earnings per share
RMB11.99 cents, +1.7%

Corporate Governance

Corporate Governance

Financial Reports

Financial Reports

Financial Summary

Financial Summary

IR Contacts

Address : Suite 3206, 32/F, Central Plaza,
18 Harbour Road, Wanchai, Hong Kong
Tel : (852) 2500 3144
Fax : (852) 2802 4552
E-mail : ir@cspc.hk
© Copyright 2023 CSPC Pharmaceutical Group Limited. All Rights Reserved.